Restoring Sleep Architecture with Medical Cannabis
Chronic insomnia affects more than 30% of adults, contributing to cardiovascular risk, anxiety, and immune dysfunction. Research demonstrates that targeted cannabinoid therapies can reduce sleep latency (time to fall asleep) and decrease nighttime awakenings.
The Role of Cannabinol (CBN)
As THC ages and oxidizes, it converts into Cannabinol (CBN). When combined with small doses of THC and sedating terpenes such as myrcene and terpinolene, CBN promotes deep physiological relaxation without the heavy morning grogginess common to synthetic pharmaceuticals.